Xeljanz, Xr - Tofacitinib, Xr 11 mg / 1 Tablet 14 Tablet, Extended Release

Reference details for licensed healthcare facility review and verification.

tofacitinib, Xr NDC Family 63539-0501 tofacitinib, Xr 11 mg / 1

NDC 11	63539-0501-14
Product NDC	63539-0501
Generic Drug Name	tofacitinib, Xr
Brand Name	Xeljanz, Xr
Manufacturer	U.S. Pharmaceuticals
Strength	11 mg / 1
Dosage Form	Tablet
Drug Type	Oral
Package Quantity	14 Tablet, Extended Release
Package Description	14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14)
Active Ingredients	Tofacitinib Citrate
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this exact presentation or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other exact NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

tofacitinib, Xr 11 mg / 1 Tablet is tracked under NDC 63539-0501-14 and rolls up into product family 63539-0501. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.

Package configuration: 14 Tablet, Extended Release.
Manufacturer: U.S. Pharmaceuticals.
Dosage form: Tablet.
Family size: 2 indexed presentations.

Click a tag to refine the catalog view around this exact presentation.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Alternate presentations in this family

These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Xeljanz, Xr - Tofacitinib, Xr 11 mg / 1 Tablet 30 Tablet, Extended ReleaseNDC 63539-0501-30 | 30 Tablet, Extended Release | U.S. Pharmaceuticals

Xeljanz, Xr - Tofacitinib, Xr 11 mg / 1 Tablet 14 Tablet, Extended Release, NDC 63539-0501-14, is a U.S. Pharmaceuticals 11 mg / 1 tablet presentation packaged as 14 Tablet, Extended Release.

NDC search formats

Canonical NDC 11: 63539-0501-14
Digits-only NDC 11: 63539050114
Possible 10-digit display format: 63539-501-14 (6353950114)

Helpful product links

Search by brand name: Xeljanz, Xr
Exact NDC 11: 63539-0501-14
Product family NDC: 63539-0501
Other package sizes in this family: 30 Tablet, Extended Release
Compare related presentations: Xeljanz, Xr - Tofacitinib, Xr 11 mg / 1 Tablet 30 Tablet, Extended Release
VA classification code: IM900
VA classification code description: IMMUNOLOGICAL AGENTS,OTHER
CMOP ID: T0928
VUID: 4035481